Kringle Pharma, Inc. (4884.T)

JPY 814.0

(-0.73%)

Annual Cash Flows

(In JPY)
Breakdown 2023 2022 2021 2020 2019
Operating Cash Flow -689.09 Million 15.79 Million -560.92 Million -146.46 Million -338.8 Million
Net Income -852.66 Million -330.33 Million -299.67 Million -116.34 Million -302.05 Million
Depreciation & Amortization - - - - -
Deferred income taxes - - - - -
Stock-based compensation - - - - -
Change in working capital 37.17 Million 73.01 Million -235.41 Million -81.72 Million -12.01 Million
Other non-cash items -22.04 Million -67.51 Million -111.33 Million -44.97 Million 10.94 Million
Investing Cash Flow -120.87 Million -254.38 Million - - -
Investments in PPE - - - - -
Acquisitions - - - - -
Investment purchases -120.87 Million -254.37 Million - - -
Sales/Maturities of investments - - - - -
Other Investing Activities -120 Million -9000.00 - - -
Financing Cash Flow 69.16 Million 603.11 Million 595.9 Million 2.08 Billion -
Debt repayment - - - - -
Dividends payments - - - - -
Common Stock Repurchased - -30 Thousand -45 Thousand - -
Common Stock Issuance 67.92 Million 602.07 Million 612.23 Million 2.08 Billion -
Other Financing Activities 1.24 Million 1.06 Million -16.28 Million 2.08 Billion -
Accounts receivables -7 Million 6 Million 99 Million -105 Million -16.52 Million
Accounts payables - - - - -
Inventory -14.18 Million -34.78 Million -268.72 Million -27.2 Million -19.16 Million
Other working capital -81 Million 11 Million -135 Million -21 Million 23.67 Million
Cash at beginning of period 2.5 Billion 2.13 Billion 2.1 Billion 166.47 Million 505.27 Million
Cash at end of period 1.76 Billion 2.5 Billion 2.13 Billion 2.1 Billion 166.47 Million
Capital Expenditure - - - - -
Effect of forex changes on cash - - - - -
Net cash flow / Change in cash -740.8 Million 364.52 Million 34.98 Million 1.93 Billion -338.8 Million
Free Cash Flow -689.09 Million 15.79 Million -560.92 Million -146.46 Million -338.8 Million

Cash Flow Charts